Public Health Product Hops
Bill of Health
APRIL 24, 2023
Yet Dmitry Karshtedt held otherwise at the ASLME Health Law Professor’s Conference in Atlanta, GA in 2017. In each scenario, public health considerations drove the product switches and the FDA actively encouraged the development of reformulated products. My talk was titled “Legal Approaches to Ensuring Timely Generic Drug Availability.”
Let's personalize your content